09.01.2024 – Annual meeting with Andrén Lab
Picture from post lab meeting dinner with Per Andrén’s group at Uppsala university.
Poster at ACNP23 in Tampa, FL
PhD student Marcus presenting some of his work on TAAR1 at the ACNP 2023 conference.
Left: Marcus and John A. Allen (University of Texas Medical Branch)
Right: Nina Dedic (Sunovion), Marcus
Visit and talk from Professor Michael Kaplitt
New publication in Nature Communications
See PhD student Yachao He’s first author paper about prosaposin and Parkinson’s here
Lab day 2023
31.03.23 – Per inaugurated as a member of the Royal Swedish Academy of Sciences
March 2023 – Neurolixis Announces Positive Ph2A Proof-of Concept on NLX-112 in Levodopa-Induced Dyskinesia in Parkinson’s Disease
A Phase IIA clinical trial for treating LID using a novel small molecule performed in collaboration with our clinical team has yielded positive results. Click below to download the full press release.